Former CDC Director advocates for additional MMR dose for babies, going against decades of vaccine safety recommendations

• • Former CDC Director Rochelle Walensky is urging for an additional MMR dose for infants aged 6-11 months in high-risk areas.

• • Even the biggest vaccine pushers do not recommend the MMR vaccine before one year of age, due to safety concerns.

• • The push for an extra MMR dose comes despite a lack of safety data for administering the vaccine to young babies.

• • A suspected measles case in Arizona was determined to be a rare reaction to the MMR vaccine, not an actual measles infection.

• • Concerns are raised about the potential risks of annual MMR boosters, including serious adverse events and the mischaracterization of vaccine reactions as measles cases.

The push for an extra MMR dose

Former Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky called for an additional MMR dose for infants aged 6-11 months, particularly in areas experiencing measles outbreaks. Walensky and her colleagues have argued in op-eds published in the Journal of the American Medical Association (JAMA) and STAT News that the current immunization guidelines should be revised. They propose that infants traveling to regions with a higher probability of measles exposure, whether domestically or internationally, should receive an extra MMR dose between the ages of 6-11 months. This recommendation is based on the uptick in measles cases in the United States.